Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Self-Concept01:19

Self-Concept

1.7K
Self-concept is the cognitive and emotional understanding individuals hold about their identity. It evolves through various developmental stages, beginning in infancy and maturing as children grow. This concept influences how individuals perceive their abilities, interact with others, and manage challenges throughout life.
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
1.7K
Bioavailability: Overview01:17

Bioavailability: Overview

443
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
443
Bioavailability: Overview01:13

Bioavailability: Overview

4.4K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.4K
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

356
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
356
Concepts and Prototypes01:24

Concepts and Prototypes

548
The human nervous system handles vast amounts of information by translating sensory stimuli into neural impulses, which the brain processes, creating thoughts expressed through language or stored as memories. The brain also synthesizes information from emotions and memories, which significantly influence thoughts and behaviors. This intricate process creates a comprehensive mental picture.
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
548
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

212
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of psychiatric-physical multimorbidity and continuity of care in seniors' medical emergency visits.

Scientific reports·2026
Same author

Hidden pathways: Detection and quantification of microplastics across treatment stages of pharmaceutical WWTPs.

Journal of hazardous materials·2026
Same author

Visualization of the interaction between sphingomyelin and cholesterol in lipid bilayer membranes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Gut microbiota shifts in spaceflight: a case study evidence and countermeasures for microbial homeostasis.

3 Biotech·2026
Same author

Silk fibroin-coated resveratrol solid lipid nanoparticles for diabetic wound healing.

Scientific reports·2026
Same author

Assessment of the safety and efficacy of micronized encapsulated ferric pyrophosphate in patients with iron deficiency anaemia: a phase-IV open-label clinical study.

Artificial cells, nanomedicine, and biotechnology·2026

Related Experiment Video

Updated: Feb 4, 2026

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
13:16

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems

Published on: December 24, 2014

10.9K

Bioformulative concepts on intracellular organ specific bioavailability.

Nikhitha K Shanmukhan1, Arun Radhakrishnan1, Vinoth Maniarasan2

  • 1Department of Pharmaceutics, JSS College of Pharmacy, Udagamund, JSS Academy of Higher Education & Research, Mysuru, India.

Therapeutic Delivery
|October 3, 2018
PubMed
Summary

Understanding drug bioavailability is key to therapeutic efficacy. This study explores organ-specific bioavailability for improved drug dosing and targeting, going beyond general plasma levels.

Keywords:
bioavailabilityintracellular bioavailabilityorgan specific bioavailabilitysystemic bioavailability

More Related Videos

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
06:34

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

5.7K
In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method
06:57

In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method

Published on: May 30, 2025

754

Related Experiment Videos

Last Updated: Feb 4, 2026

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
13:16

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems

Published on: December 24, 2014

10.9K
The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
06:34

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

5.7K
In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method
06:57

In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method

Published on: May 30, 2025

754

Area of Science:

  • Pharmacology
  • Drug Delivery
  • Biopharmaceutics

Background:

  • Bioavailability is crucial for drug therapeutic efficacy.
  • General plasma bioavailability may not reflect organ-specific drug concentrations.
  • Accurate bioavailability data is essential for effective drug development and dosing.

Purpose of the Study:

  • To introduce the concept of bioavailability and its importance.
  • To discuss regulatory aspects and kinetic data related to bioavailability.
  • To explore novel bioformulative approaches for enhancing organ-specific bioavailability.

Main Methods:

  • Review of existing literature on bioavailability.
  • Analysis of pharmacokinetic data.
  • Discussion of formulation strategies for targeted drug delivery.

Main Results:

  • Bioavailability is a fundamental determinant of drug efficacy.
  • Organ/tissue-specific bioavailability offers a more precise approach to dose calculation.
  • Novel formulations can improve drug targeting and bioavailability in specific organs.

Conclusions:

  • Understanding and calculating organ-specific bioavailability is vital for optimizing drug therapy.
  • This approach can significantly improve drug research and organ-targeting strategies.
  • Moving beyond plasma bioavailability enhances therapeutic outcomes and reduces potential side effects.